These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 36566366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry.
    Kelly ME, O'Sullivan NJ, Bolger JC, Polignano F, Youssef H, Renehan A, Malcomson L, Alves S, Cecil T, Mulsow J, Moran B, Mohamed F, UK & Ireland Colorectal Peritoneal Metastases Registry.
    Br J Cancer; 2023 Jan; 128(1):42-47. PubMed ID: 36347966
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy.
    Zhou S, Jiang Y, Liang J, Pei W, Zhou Z.
    World J Surg Oncol; 2021 May 17; 19(1):151. PubMed ID: 34001125
    [Abstract] [Full Text] [Related]

  • 9. Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.
    Vassos N, Förtsch T, Aladashvili A, Hohenberger W, Croner RS.
    World J Surg Oncol; 2016 Feb 24; 14(1):42. PubMed ID: 26912149
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Actual 5-Year Survival After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis of Colorectal Origin.
    Sarfaty E, Khajoueinejad N, Yu AT, Hiotis S, Golas BJ, Sarpel U, Labow DM, Cohen NA.
    Ann Surg Oncol; 2024 Mar 24; 31(3):1970-1979. PubMed ID: 37989953
    [Abstract] [Full Text] [Related]

  • 12. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM.
    Ann Surg Oncol; 2015 May 24; 22(5):1716-21. PubMed ID: 25145504
    [Abstract] [Full Text] [Related]

  • 13. Outcomes following synchronous liver resection, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal liver and peritoneal metastases: A bi-institutional study.
    Flood MP, Waters PS, Kelly ME, Shields C, Conneely J, Ramsay R, Michael M, Loveday B, Warrier SK, Mulsow J, Heriot AG.
    Surg Oncol; 2021 Jun 24; 37():101553. PubMed ID: 33839444
    [Abstract] [Full Text] [Related]

  • 14. Patterns and Timing of Recurrence following CRS and HIPEC in Colorectal Cancer Peritoneal Metastasis.
    Hassan S, Malcomson L, Soh YJ, Wilson MS, Clouston H, O'Dwyer ST, Kochhar R, Aziz O.
    Eur J Surg Oncol; 2023 Jan 24; 49(1):202-208. PubMed ID: 35987797
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-term outcomes of elderly patients with peritoneal metastases of colorectal origin after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Weksler Y, Hoffman A, Green E, Kyzer M, Nevo N, Gerstenhaber F, Greenberg R, Klausner JM, Gutman M, Lahat G, Berger Y, Geva R, Nizri E.
    Surg Oncol; 2022 Sep 24; 44():101848. PubMed ID: 36126349
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
    Burnett A, Lecompte MA, Trabulsi N, Dubé P, Gervais MK, Trilling B, Cloutier AS, Sideris L.
    World J Surg Oncol; 2019 May 15; 17(1):83. PubMed ID: 31092250
    [Abstract] [Full Text] [Related]

  • 20. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
    Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutiérrez Calvo A, Regueira FM, Casado-Adam Á, Cascales-Campos PA, Arteaga X, García-Fadrique A, Gómez Sanz R, López García A, Zozaya G, Arjona Á, Gil Martínez J.
    Ann Surg Oncol; 2019 Aug 15; 26(8):2615-2621. PubMed ID: 31115852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.